These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 368946)

  • 1. [Why does tetanus not occur among Brazilian Amerindians of the Amazon region? A critical analysis of the problem and the elements involved].
    Veronesi R; Oliveira Angelo MJ; Baruzzi RG; Santa Rosa CA; Souza Carvalho RP; Franco LJ; Focaccia R; Mazza CC; Feldman C; Bazzone JR; Oliveira CE
    Rev Hosp Clin Fac Med Sao Paulo; 1978 Oct; 33(5):237-42. PubMed ID: 368946
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tetanus, typhoid and smallpox antibodies in the sera of men 22-46 years of age].
    Bilecki S; Gall W; Golińska Z; Zóltowski Z
    Przegl Epidemiol; 1974; 28(4):433-45. PubMed ID: 4374726
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of blood transfusion on specific anti-tetanus immunity].
    Korableva NN; Khors NP
    Gematol Transfuziol; 1989 Mar; 34(3):26-9. PubMed ID: 2656373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the status of cellular and humoral immunity against tetanus].
    Doutlík S; Vacek Z; Deutschmannová J
    Cas Lek Cesk; 1984 Sep; 123(38-39):1182-6. PubMed ID: 6388846
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of clinical tetanus in a patient with protective antitetanus antibody level.
    Beltran A; Go E; Haq M; Clarke HB; Zaman M; Recco RA
    South Med J; 2007 Jan; 100(1):83. PubMed ID: 17269536
    [No Abstract]   [Full Text] [Related]  

  • 6. New concepts on tetanus immunization: naturally acquired immunity.
    Veronesi R; Cecin H; Corrêa A; Tavares J; Moraes C; Bertoldo OJ
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(1):126-34. PubMed ID: 1092755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of administration of blood products on the course of tetanus antibody concentration in immuno-incompetent patients].
    Pietsch M; Töre S; Schütt KH
    Infusionsther Transfusionsmed; 1996 Feb; 23(1):25-8. PubMed ID: 8653012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of a numerically additive combined vaccine against tetanus and smallpox].
    Mayr A; Baljer G; Wagner C; Sailer J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response in tetanus.
    Gaitonde BB; Chanderkar NG; Saldanha FL; Dastur FD; Dixit SK; Awatramani VP; Nair KG
    J Assoc Physicians India; 1979 Aug; 27(8):699-705. PubMed ID: 317289
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tetanus in vaccinated individuals].
    Janout V; Machálek J; Smékal M
    Cesk Epidemiol Mikrobiol Imunol; 1984 Sep; 33(5):274-81. PubMed ID: 6238679
    [No Abstract]   [Full Text] [Related]  

  • 11. Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain.
    Plans-Rubió P
    Vaccine; 2004 Sep; 22(29-30):4002-13. PubMed ID: 15364450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunogenic capacity of soluble "vaccinia" antigen (fractionated smallpox vaccine) administered simultaneously with inactivated typhoid vaccine and with purified and concentrated tetanus anatoxin].
    Mihăilescu R; Dimache G; Velea V; Stoean C; Croitoru M; Durbacă S; Chirescu N
    Arch Roum Pathol Exp Microbiol; 1989; 48(2):151-6. PubMed ID: 2699409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune response in active-passive immunization against tetanus].
    Bozović M
    Med Pregl; 1986; 39(7-8):327-9. PubMed ID: 3547064
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological protection against tetanus].
    German A; Fattal-German M; Bizzini B
    Bull Acad Natl Med; 1987 Jun; 171(6):735-41. PubMed ID: 3325148
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tetanus: antibody levels and vaccination history in a target group of the Latium population].
    Mastroeni I; Tarsitani G; Vescia N; Cantalamessa Carboni L; D'Arca T; De Stefanis B; Feola P; Raponi A
    Nuovi Ann Ig Microbiol; 1988; 39(2):149-60. PubMed ID: 3072525
    [No Abstract]   [Full Text] [Related]  

  • 16. High diversity of HHV-8 molecular subtypes in the Amazon region of Brazil: evidence of an ancient human infection.
    Ishak Mde O; Martins RN; Machado PR; de Souza LL; Machado LF; Azevedo VN; Katano H; Sata T; Hasegawa H; Vallinoto AC; Ishak R
    J Med Virol; 2007 Oct; 79(10):1537-44. PubMed ID: 17705167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of tetanus immunity in the Kocaeli Region, Turkey.
    Dundar V; Yumuk Z; Ozturk-Dundar D; Erdoğan S; Gacar G
    Jpn J Infect Dis; 2005 Oct; 58(5):279-82. PubMed ID: 16249621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitetanus and antidiphtheria immunity in newborns.
    Durbacă S
    Roum Arch Microbiol Immunol; 1999; 58(3-4):267-72. PubMed ID: 11845464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplacental antibodies. Part II: Maternal antibodies against the toxins of C. diphtheriae and C. tetani.
    Celko A; Burianová B; Kŕíz B; Zikmundová V; Zikmund V; Stríbrný J
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(1):83-8. PubMed ID: 3921608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of the level of immunity in organized collectives in performing epidemiologic surveillance for diphtheria, tetanus and measles].
    Kolkov VF; Vasil'eva VI; Rusakova EV
    Voen Med Zh; 1988 Jul; (7):46-9. PubMed ID: 3143180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.